The Wilms' tumour suppressor gene WT1 encodes a zinc ®nger protein that is mutated in a subset of Wilms' tumours. Mutation screening and animal studies revealed essential roles during development and later function of the kidneys and the entire genitourinary system. Sequence similarity suggested a possible role for WT1 as a transcription factor. Indeed, sequence speci®c DNA binding and transcriptional activation or repression potential could be demonstrated in transient transfection assays with various reporter constructs. To identify endogenous WT1 target genes we established HEK293 cell lines expressing the dierent WT1 isoforms in a tetracycline dependent manner. Dierential display PCR (ddPCR) was performed on RNA from stable WT1 transfected HEK293 cell lines and two other WT1 transfected lines (G401 and Saos-2). In an extended survey of several thousand ddPCR bands only few dierences in intensity were seen and none of these could unambiguously be veri®ed as being WT1 regulated by subsequent Northern blot analysis. In addition, almost none of the WT1 target genes identi®ed to date in transient co-transfection assays could be con®rmed by either ddPCR or Northern hybridization in the three stable transfected cell lines. Among the nine genes expressed, the only exceptions were CSF1 and to a lesser extent IGF1R being induced in Saos-2/G401 and HEK293 cells, respectively. At least two of the cell lines tested had previously shown clear biological eects though ± either WT1 dependent apoptosis (Saos-2) or greatly reduced tumorigenicity (G401). This suggests
Introduction
Originally identi®ed by its inactivation in Wilms' tumours, the WT1 gene is known to play an essential role in regular development of the kidney and the genitourinary system (reviewed in Reddy and Licht, 1996) . WT1 expression has been detected in speci®c cell types of the developing kidney and gonads, the spleen, mesothelial cells and parts of the central nervous system. WT1 knock out mice fail to develop kidneys and the embryos die early during embryogenesis (Kreidberg et al., 1993) . While tumour development has not been observed in WT1 (+/7) mice, inactivation of WT1 in nephroblasts frequently leads to tumour formation in humans. Direct evidence for a tumour suppressing function has been provided by overexpression of WT1 in G401 Wilms' tumour cells resulting in a sharply decreased tumour incidence and longer latency in a nude mouse assay (McMaster et al., 1995) .
Several human WT1-associated diseases have been characterized: In the WAGR syndrome (Wilms' tumour, aniridia, genitourinary malformations and mental retardation) hemizygous deletions of WT1 lead to hypospadias and kryptorchidism. Denys ± Drash syndrome (DDS), characterized by glomerulopathy, intersex and Wilms' tumour is predominantly due to heterozygous missense mutations in the zinc ®nger domain (e.g. R394W) . These alter the DNA binding potential of the protein and create dominant negative alleles. In both syndromal Wilms' tumours the second WT1 allele is typically inactivated as well. Finally, translocations leading to a fusion of the transactivating domain of the Ewing sarcoma gene (EWS) and parts of the zinc ®nger region of WT1 have been found as an oncogene in desmoplastic small round cell tumour (DSRCT) (Gerald et al., 1995) .
Although the physiological function of WT1 is poorly understood, it is well characterized on the molecular genetic level. Two functional domains have been described: a proline/glutamine-rich transregulatory domain in the N-terminal part and four Kruppeltype zinc ®ngers at the C-terminus (Call et al., 1990; Gessler et al., 1990) . Both motifs are found in several transcription factors suggesting a function in transcriptional regulation. The N-terminal region has indeed been demonstrated to contain transcriptional activation and repression domains. The zinc ®ngers show extensive homology to those of the early growth response-1 protein (EGR1). Similar to EGR1, the WT1 zinc ®ngers can bind to a GCGGGGGCG sequence (Madden et al., 1991; Rauscher et al., 1990) .
Alternative splicing at two sites leads to the expression of four WT1 isoforms that dier in the presence or absence of either exon 5 or a three amino acid extension (KTS) at the end of exon 9 (Gessler et al., 1992; Haber et al., 1991) . Only the latter is conserved throughout evolution (Kent et al., 1995) . Immunostaining experiments uncovered a distinct subnuclear distribution of WT1 isoforms: the +KTS isoform co-localized with splicing domains whereas the 7KTS isoform was diusely distributed like transcription factors, suggesting that WT1 may not only function in transcriptional regulation but also in RNA processing . This notion is further supported by the demonstration of sequence speci®c RNA binding by WT1 (Caricasole et al., 1996) .
Quite distinct functional roles for WT1 +/7KTS isoforms are evident from recent analysis of Frasier syndrome which is characterized by focal glomerular sclerosis, kidney failure during adolescence and complete gonadal dysgenesis in males (Barbaux et al., 1997; Kikuchi et al., 1998; Klamt et al., 1998) . Heterozygous splice site mutations in all cases examined lead to an imbalance of +/7KTS isoforms. While normal cells show an invariant ratio of approximately 2 : 1 between +KTS and 7KTS isoforms, this ratio becomes inverted in Frasier syndrome and most severely perturbs male genital development. Whereas GC-rich, EGR1 like motifs are bound by both +KTS and 7KTS isoforms, an additional TC-rich sequence was found to be recognized preferentially by the 7KTS isoform (Wang et al., 1992) . Several variations of these consensus sites have been identi®ed in binding site selection experiments. Such WT1-binding motifs are present in the promoter regions of a number of genes, e.g. EGR1, IGF2, PDGFA, EGFR, PAX2 and CSF1 (Madden et al., 1991) . Promoter analysis of these genes using transient cotransfection assays with reporter constructs revealed a transcriptional repression, or in cases activation by WT1. Of note, however, transcriptional regulation could only be seen when large amounts of reporter constructs and WT1 expression plasmids driven by strong CMV promoters were used. This clearly does not re¯ect physiological conditions. Furthermore, expression of these putative WT1 target genes is not correlated with WT1 levels in dierent tissues (Langerak et al., 1995; Vicanek et al., 1997) .
To identify endogenous WT1-regulated genes we established HEK293 cell lines transfected with one of the four WT1 isoforms or a DDS mutant, respectively. These cells express low levels of endogenous WT1 and were thus expected to be capable of responding to WT1. An improved version of dierential display PCR (ddPCR) was used to identify genes that are up-or down-regulated in response to WT1 in these cells and similar Saos-2 transfectants. Furthermore, expression of previously identi®ed WT1 target genes was tested in three stable cell systems.
Results

Development of stable cell lines expressing WT1
For controlled expression of WT1 isoforms in HEK293 the tetracycline repressible transactivator system was used (Gossen and Bujard, 1992) . The system is based on a tetracycline sensitive transactivator (tTA) that stimulates transcription from a minimal promoter containing tet operator sequences. The tTA expression vector pUHD15-1 was stably transfected into HEK293 cells and individual clones were tested for their ability to regulate a tetracycline dependent luciferase reporter construct (pUHD13-3) in transient transfections. The strongest regulation was found in clone neo1, showing a 40-fold induction in the absence of tetracycline despite relatively high background levels that are common in transient transfections. This clone was used to stably transfect constructs encoding the four dierent WT1 isoforms and a DDS mutant (Figure 1 ) under control of the tTA-regulated promoter of pUHD10-3. At least one stable cell line could be isolated for each isoform and the resulting clones were tested for WT1 expression by Western blot analysis. Except for the +/7 isoform (CW2), extremely little or no WT1 protein was detected in the repressed state, whereas removal of tetracycline for 48 h led to a strong induction of WT1 expression (Figure 2a ). WT1 protein could already be seen after 6 h of induction, reaching a maximum after 24 h. Although repression of the promoter seemed to be complete on the protein level, Northern blot hybridizations revealed a low background transcription from the transfected constructs (Figure 2b) .
In several other cell systems WT1 overexpression has been reported to lead to apoptosis either directly or after external stimulation. None of the WT1 expressing HEK293 cell lines, however, showed signs of apoptosis in dierent assays (not shown).
Dierential display analysis
In the initial display screening with RNA from WT1 transfected HEK293 clones about 200 dierences in band intensities were detected and partially characterized. Subsequent analyses, however, revealed that these dierences were only reproducible on Northern blots of the original RNA preparation, but not in any subsequent samples. The most likely reason for this was a change in fetal calf serum used for cell culture. Nevertheless, these results indicated that ddPCR was extremely sensitive with a large fraction of altered Figure 1 Alternative splicing leads to four dierent WT1 isoforms. Splice I results in presence or absence of exon 5 encoding 17 amino acids. Alternative splice II diers in three amino acids (KTS) between zinc ®ngers three and four due to the case of two alternative splice donor sites. The dominant negative point mutation R394W in exon 9 of Denys-Drash Syndrome patients (DDS) was generated by PCR mutagenesis in CW3 (*) bands being due to real dierences in RNA abundance in the respective samples, provided that culture techniques are highly standardized.
In a repeated ddPCR screening the 90 most informative primer pairs of the ®rst round were employed ( Figure 3 ). The set of RNA samples was extended to include 12 cell lines grown under tightly controlled tissue culture conditions: parental HEK293 cells and four lines with WT1 splice isoforms together with the DDS mutant; parental and two WT1 transfected Saos-2 lines (WT1+KTS and WT17KTS) ± in the induced and repressed state (Englert et al., 1995) . To a limited extent parental and transfected G401 Wilms' tumour cells (+KTS and 7KTS) were also included. WT1 expression is not regulated in these cells, however, and adaptive processes may have occurred. These cell lines showed a large number of dierences, but they were in part seen between lines containing the same WT1 isoform suggesting that the cells have undergone substantial clonal evolution. Therefore, G401 derivatives were only used to test altered expression of candidate WT1 target genes in subsequent experiments.
An average number of 100 bands per lane could be scored on each ddPCR gel. Thus, a large fraction of mRNA species present in these cells has been covered in this screen. The vast majority of bands appeared to be in common to all cells used. HEK293 and Saos-2 cells exhibited only seven and three internal dierences in banding patterns, respectively. More important, these dierences were always limited to transfectants of one cell type and they could not be seen in the other cell system. The corresponding PCR products were excised from dried gels, reampli®ed and directly sequenced. Seven of these sequences proved to be readable and six of them provided matches to known genes or EST sequences from databases. To assess dierential expression of these genes, Northern blot analyses were performed with cloned probes, relying on cDNA clones from the IMAGE consortium or direct RT ± PCR ampli®cation of cDNA probes using unique gene speci®c primers.
Five ddPCR sequences were derived from HEK293 cells. Two independent clones identical to part of the cytochrome c oxidase gene were disregarded since mitochondrial genes are frequent contaminants in dierential expression screens and tetracycline is expected to in¯uence mitochondrial metabolism. A third clone contained only Alu repetitive sequences and could not be studied. One PCR fragment was Similar levels of WT1 can be seen upon induction. Due to incomplete repression of the tet-hCMV promoter clone CW2 expresses signi®cant levels of WT1 in the uninduced state. No WT1 protein can be seen in the founder cell line expressing tTA (neo). (b) Northern blot of total RNA hybridized with a BamHI/ Agel fragment of WT1 cDNA. Low levels of endogenous WT1 mRNA (2.9 kb) can be seen in all cell lines (WT1). The shorter transcript (WT1*) from the transfected construct (2.4 kb) is expressed at high levels in induced cells and displays low background expression in the repressed state. Again repression in clone CW2 is incomplete. Size dierences between transcripts are due to altered untranslated regions Figure 3 Dierential display of mRNA from WT1 transfected cell lines with primers gcgcaagcttttttttttttcc (B) and cgggaagcttactccatgactc (11). The autoradiograph shows one of the rare examples with dierences in banding pattern. The marked band (?) was excised from lane 5 (SD22+), reampli®ed and sequenced. For ddPCR RNA was used from the following WT1 transfected cell clones: Saos-2 parental clone expressing tTA (1, 2), WT1+/7 (3, 4) or WT1+/+ (5, 6) grown in presence (lanes 1, 3 and 5) or absence of anhydrotetracycline (lanes 2, 4 and 6); HEK293 cells expressing tTA (7) and the derived cell clones expressing WT17/7 (8), WT17/+ (9), WT1+/7 (10), WT1+/ + (11) or WT17DDS (12) in the induced state. The dried polyacrylamide gel was exposed for 12 h WT1 target gene expression C Tha Äte et al derived from the nonmuscle myosin heavy chain gene. A corresponding cDNA probe did not hybridize on Northern blots, suggesting that expression levels are very low or the sequences represent a ddPCR artefact. Finally, one sequence showed a match to a human chromosome 7 clone (gb:AF006752). Hybridization of a PCR generated probe (using primers based on genomic sequence) revealed an unaltered expression pattern irrespective of WT1 induction. Thus, none of the HEK293 derived cDNA-clones could be veri®ed.
From the Saos-2 cells two sequences were obtained. One of them showed no similarity to known sequences in the database. Again, a hybridization probe was generated by RT ± PCR using gene speci®c primers. Northern blot hybridization revealed no changes in expression pattern in Saos-2 lines suggesting that the corresponding ddPCR band represents an artefact, i.e. ampli®cation failure in parental Saos-2 cells. No hybridization signal of this probe could be seen in HEK293 cell lines as expected from the results of ddPCR. Reproducible results could only be obtained for the calcium binding protein gene CAPL. Hybridization with the cDNA probe revealed a cell clone speci®c expression pattern matching the ddPCR results. The variations in expression levels appeared to be rather cell clone than WT1 dependent however, again suggesting clonal evolution as the likely cause for the dierence seen.
Northern blot analysis of known WT1 target genes
Promoters of numerous genes have been described in the literature as being WT1 regulated. None of these genes has been identi®ed in our dierential display PCR screen, however. Therefore, Northern blot analysis was performed using RNA from the WT1 transfected stable cell lines. In the case of HEK293 and Saos-2 with inducible WT1 expression, RNA from both, induced and repressed cells was tested. G401 derived cells with constitutive expression were included as additional control cell lines. The results are summarized in Table 1 . None of the genes tested displayed a clear WT1 dependent expression in all cell types. Most of them were either constitutively expressed ± irrespective of WT1 ± or not expressed at all within the detection limit of Northern blot analysis (Figure 4) .
The most clear-cut exception was the CSF1 gene. In two independent Saos-2 WT17KTS clones CSF1 expression was signi®cantly higher compared to both, the parental clone or cells transfected with WT1+KTS. Importantly, this increase was only seen in the WT1 induced state. G401 cells showed a similar, but much weaker increase in the WT17KTS transfected cells, while HEK293 cells showed extremely low expression of CSF1, that could not reproducibly be quanti®ed. Interestingly, an induction of CSF1 transcripts speci®cally by WT17KTS was also seen in U20S osteosarcoma cells with tetdependent WT1 expression (data not shown).
Expression of the IGF1 receptor gene is increased by a factor of approximately two in HEK293 WT1+KTS transfected cells and not in the WT17DDS clone that has a +KTS origin. There was no dierence, however, between the induced and uninduced state. This could be due to high back- Figure 4 Northern blot analysis of previously identi®ed WT1 target genes. RNA from WT1 stably transfected cell lines HEK293, Saos-2 and G401 was hybridized with cDNA clones of potential WT1 target genes. Hybridizations were done on a set of similar ®lters. A hybridization of representative ®lters with a 28S oligonucleotide probe is shown in the bottom row. Signal strength has been determined with a Phosphorimager revealing loading dierences of +20% for HEK293 and Saos-2 clones and +4% for G401 clones. For HEK293 and Saos-2 cells RNA from repressed (+tet) and induced (7tet) cultures was used. The Saos-2 clones are transfected with tTA expression vector only (SP2), or WT1+/7 (SB19) and WT1+/+ (SD22). The G401 clones carry empty vector (WTF116.33), WT1+/7 (WTF116.26A) or WT17/+ (WTF116.13A). Densidometric analyses of autoradiograms did not reveal signi®cant changes except for cases described in the text WT1 target gene expression C Tha Äte et al ground transcription of WT1 in the repressed state. Saos-2 and G401 cell lines express IGF1 receptor at constant levels regardless of WT1 state. Finally, variable levels of EGR1 expression were found in Saos-2 and G401 transfectants. In Saos-2 cells EGR1 expression turned out to be dependent on tissue culture conditions and variable levels were even found in repeated RNA preparations from the same cell clone. In G401 cells a WT1 independent, but cell line speci®c expression of EGR1 was seen.
Discussion
Several features of the WT1 protein strongly suggested that WT1 should function as transcription factor. The zinc ®nger domain of WT1 could be shown to bind to related GC-or TC-rich motifs by DNA mobility shift analyses and DNA footprinting (Wang et al., 1993) . The amino-terminus of WT1, when fused to foreign DNA binding domains, could repress the corresponding target promoters. Furthermore, repressing or in rare cases activating properties of WT1 could be demonstrated when target promoters were assayed in transient transfection assays. In these studies high levels of WT1 and reporter constructs must be used. This may induce squelching and it has indeed been shown that the transcriptional regulatory potential of WT1 is highly dependent on the choice of expression vector (Reddy et al., 1995) .
We have screened two dierent stably transfected cell systems expressing WT1 isoforms for genes expressed in a WT1 dependent manner. Although no method can claim comprehensive coverage, we estimate that 50% of the genes expressed in these cells were assayed in our ddPCR screening (Wan et al., 1996) providing a high level of sensitivity. Despite such an extensive survey no gene could be identi®ed that was induced or repressed by WT1. The capability of ddPCR to detect subtle variations in expression levels in a quantitative manner has not been formally addressed. We note, however, from our unpublished observations that relative dierences in transcript abundance can readily be detected in other cases. Therefore, the number of genes that are possibly regulated in our cell lines through WT1 must be quite small.
Failure to detect WT1 responsive genes should not be due to the cell system used here. It is obvious that the biological eect of any transfected gene will partly depend on the nature of the recipient cell. Although no single cell line will perfectly suit every possible requirement for such analyses, these experimental uncertainties should be minimized through the use of multiple cell lines for our studies. HEK293 cells are derived from a WT1 expressing organ, the embryonic kidney and they express low levels of endogenous WT1 suggesting that responsive promoters are likely accessible to the protein and required co-factors may be present. The use of parental cells and expression clones for all WT1 isoforms as well as the dominant negative DDS mutant should increase the potential to identify alterations in gene expression. Even if the expression of a single WT1 isoform may not aect transcription on its own, we would expect that either the dominant mutant DDS form or the induced imbalance of isoforms would still alter the function of endogenous WT1 protein. The other two cell systems tested to not express endogenous WT1, but show clear biological eects upon transfection of WT1. Saos-2 cells undergo apoptosis after prolonged expression of WT1, while WT1 transfected G401 cells display greatly reduced tumorigenic potential. If WT1 mediates these functions by directly regulating transcription of target genes, this should result in an altered mRNA abundance. In addition to the rather unbiased ddPCR screening, we have tested 16 genes that were previously reported to be WT1 regulated based on transient transfection studies with their respective promoter regions. Nine of the genes were detected by Northern blot analysis, but most of them did not show altered expression in response to WT1 in any of the cell systems used. IGF1R and especially CSF1 remained as the only candidates to show evidence of WT1 dependent expression, but limited to one of the cell lines each. While expression dierences were rather small for IGF1R with an approximately twofold induction by WT1+KTS, there was a strong increase in CSF1 expression in Saos-2 cells in response to WT17KTS. The CSF1 gene is not known to be involved in kidney development, but since both WT1 and CSF1 are expressed in certain hematopoetic cell lineages this observation may have physiological relevance there. In the current experimental system it is not possible to determine if this eect is a direct or indirect result of WT1 expression. It is interesting to note, however, that WT1 induced gene expression in both instances while there was a suppression reported in transient transfections. This inconsistency may be related to the ®nding of Reddy and co-workers (Reddy et al., 1995) who showed that WT1 can act as a repressor or activator in transient transfections depending on its expression level.
The almost complete lack of WT1 dependent gene expression in our assays is supported by the absence of a correlation between the expression of putative target genes and WT1 itself as reported in the literature. When putative WT1 target genes were tested for expression in mesothelial cell lines no correlation with endogenous WT1 expression levels could be found (Langerak et al., 1995) . Similarly, EGFR expression is not altered by the presence of a dominant negative WT1 allele in the kidney of a DDS patient (Vicanek et al., 1997) . It is also worth noting, that with few exceptions no attempt was apparently made in previous studies to show that the endogenous copy of postulated WT1 target genes is expressed in a WT1-dependent manner.
The WT1 transfected Saos-2 cells were previously shown to express the endogenous EGF receptor gene in a WT1 dependent fashion (Englert et al., 1995) . This was demonstrated by immunoprecipitation of metabolically labelled protein. The steady state mRNA levels, however, remained unchanged upon WT1 induction. This puzzling observation together with the lack of WT1-dependent gene expression in all three cell systems in the present report raises the question whether WT1 may exert its function at a level dierent from transcriptional control. It has been suggested that WT1 contains a RNA binding motif. Furthermore, direct binding of WT1 protein to the 5' untranslated region of IGF2 RNA could be demonstrated in vitro (Caricasole et al., 1996) . Any alterations by WT1 of mRNA processing, translational availability or RNA modi®cation would not necessarily alter steady state levels of mRNA which are measured by ddPCR and Northern blot analysis. Distinct subnuclear localization of WT1 isoforms in domains that are thought to be relevant to splicing provides additional evidence that WT1 may act at a posttranscriptional level Larsson et al., 1995) .
Direct evidence for transcriptional regulation has recently been obtained for the EWS-WT1 fusion protein found in desmoplastic small round cell tumors. In this case three of the four WT1 zinc ®ngers are fused to the EWS transactivating domain. The fusion protein is capable of speci®cally activating the endogenous PDGFA gene, but the lack of zinc ®nger I and addition of a completely unrelated aminoterminus may well create a protein that is targeted to new cellular sites and performs functions quite distinct from normal WT1 protein (Lee et al., 1997) . Similar to the present study no eect of wild type WT1 could be detected on the expression of PDGFA and a number of other putative target genes. Most recently, Kim et al. (1998) have shown that DNA binding by the EWS-WT1 fusion protein is much stronger compared to wild type WT1, providing additional evidence for distinct functions of these genes.
In conclusion, we have shown in three dierent cell systems that WT1 does not alter steady state mRNA levels of almost all genes that are postulated to be subject to regulation by WT1. Exceptions were CSF1 and IGF1R, but only in a cell type speci®c manner. Furthermore, extensive ddPCR analysis failed to identify any new WT1 regulated genes. Thus, the number of genes whose expression WT1 may regulate directly must be very small or additional modes of WT1 action on a posttranscriptional level have to be considered.
Materials and methods
Cell culture
Saos-2 osteosarcoma cells (Englert et al., 1995) and HEK293 cells were grown in Dulbecco's modi®ed Eagle's medium with 10% fetal calf serum. The G401 Wilms' tumour derived cell lines (McMaster et al., 1995) were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum.
HEK293 cells were transfected by calcium phosphate DNA precipitation (Chen and Okayama, 1988) . Selection of drug-resistant colonies was carried out with G418 (400 mg/ ml) or puromycin (500 ng/ml), respectively. All stable cell lines carrying tetracaycline-regulated constructs were maintained in medium containing anhydrotetracycline (100 ng/ ml).
Development of cell lines with inducible WT1 expression
Founder cell lines were generated by transfection of HEK293 cells with pUHD15-1neo, expressing the tetracycline-repressible transactivator (tTA) and the neo-marker (Gossen and Bujard, 1992) . Isolated G418-resistant colonies were tested for tetracycline-dependent gene expression by transient transfection with the tet-dependent luciferase reporter plasmid pUHD13-3. Luciferase activity was measured in lysates from cells grown in presence or absence of anhydrotetracycline (Brasier et al., 1989) .
Human cDNAs (nt 355 ± 2435 of HSWT1) for the four dierent WT1 isoforms were subcloned into pUHD10-3 to obtain expression under the control of the tTA-regulated promoter. In addition, a WT1 (+exon 5/+KTS) expression construct was created by PCR mutagenesis that carries the most frequent DDS point mutation CGG4TGG in exon 9 resulting in a 394 Arg4Trp exchange. The HEK293-tTA founder cell line was cotransfected with the WT1 constructs and pJB6puro using a 10-fold excess of the WT1 construct in presence of anhydrotetracycline. Individual puromycin resistant colonies were isolated and screened for WT1 expression upon withdrawal of anhydrotetracycline by immunoblotting.
Western blot analysis
Western blots were prepared on nitrocellulose membranes (Schleicher and Schuell) using 40 mg of cellular protein extract. Polyclonal antibodies WT-C19 or WT180 (Santa Cruz) were used at a 1 : 500 dilution followed by goat anti-WT1 target gene expression C Tha Äte et al rabbit antibody (1 : 10 000) and detection by enhanced chemiluminescence (ECL system Amersham) according to the manufacturer's recommendations.
Dierential display analysis
RNA from stable cell lines was prepared using the protocol of Chomczynski and Sacchi (1987) . Total RNA (1.0 mg) was digested for 30 min at 378C with 3 U DNasel in 16®rst strand buer (250 mM Tris-HCl pH 8.3, 375 mM KCl, 15 mM MgCl 2 ) and 5 U RNAguard in a total volume of 10 ml. After heat inactivation of the enzyme for 5 min at 908C the RNA was precipitated by adding 0.3 M sodium acetate and 2 vol ethanol. The RNA pellet was dissolved in 13 ml DEPC treated H 2 O containing 50 pmol 3'oligo-dT primer (Linskens et al., 1995) , heated to 758C for 10 min and rapidly cooled on ice. Subsequently 5.0 ml 56®rst strand buer, 2.5 ml 0.1 M DTT, 2.5 ml 250 mM dNTP-Mix, 50 U SuperScriptII reverse transcriptase (Gibco ± BRL) and DEPC-treated water ad 25 ml was added to the RNA/Primer-Mix. Reverse transcription was performed at 378C for 70 min, followed by a denaturation step at 908C for 10 min. The cDNA could be stored at 7808C. A total of 8 dierent 3'oligo-dT primers that proved to be most informative (B, C, D, E, F, H, L and M) were used in the present study combined with 10 ± 12 dierent 5' upstream primers each (Linskens et al., 1995 and our unpublished observations) . For dierential display PCR 1.0 ml of the above cDNA was mixed with 1.0 ml 106PCR buer (10 mM Tris-HCl pH 9.0, 50 mM KCl, 1.5 mM MgCl 2 , 0.1% Triton-X100, 0.2 mg/ ml BSA), 0.375 ml 100 mM dNTP, 0.625 ml 20 mM 5' upstream primer, 0.1 ml [
32 P]-a-dCTP, 5 U Taq DNA polymerase (Gibco ± BRL) and 0.025 U Pwo polymerase (AGS) in a total volume of 10 ml. The PCR mixture was overlayed with a drop of paran oil and ampli®ed using the following conditions: 60 s denaturation at 948C, eight cycles of 45 s denaturation at 948C, 60 s annealing at 418C and 120 s synthesis at 728C, followed by 15 cycles of 45 s at 948C, 45 s at 608C and 120 s 728C, completed by a ®nal extension of 5 min at 728C. The PCR reaction was mixed with 4.5 ml denaturing dye (10 mM NaOH, 95% formamide, 0.05% bromphenol blue, 0.05% xylene cyanol) and 7.0 ml aliquots were loaded on 6% denaturing polyacrylamide gels and run at 1400 V for 2.5 h in TBE (90 mM Tris-borate, 2.5 mM EDTA).
Gels were dried and exposed to X-ray ®lm for 12 ± 48 h at room temperature. Dierentially appearing bands were cut from the gel after lining up the ®lm and the gel and marking the bands by needle-pricking. One third of a gel slice was reampli®ed using the primer combinations of the original ddPCR in a total volume of 50 ml containing 60 pmol of each primer, 50 mM dNTP and 5 U Taq DNA polymerase for 30 cycles (948C for 45 s; 608C for 60 s; and 728C for 120 s) with 2 min initial denaturation at 948C and a ®nal synthesis step at 728C for 5 min.
Cycle sequencing of dierentially displayed bands
Ampli®ed bands were separated from primers by gel electrophoresis on 1.2% agarose gels and PCR products were puri®ed using the Qiagen Gel extraction kit. An aliquot of the PCR product was used in cycle sequencing (SequiTherm Cycle Sequencing kit, Biozym or Thermo Sequenase radiolabelled terminator cycle sequencing kit, Amersham) according to the supplier's protocol. Sequences were compared to Genbank and EMBL databases using the GCG software.
Northern blot hybridization
Total RNA (10 mg/lane) was separated on 1.2% agarose gels with 3% formaldehyde and 16MOPS buer (20 mM MOPS, 5 mM sodium acetate, 0.5 mM EDTA, pH 7 ± 7.5) at 120 V for 3 h. The RNA was transferred onto nylon membranes (Qiabrene, Qiagen) with 106SSC (1.5 M NaCl, 0.15 M sodium citrate) overnight followed by UV-crosslinking. Probes were labelled with 30 mCi 32 P-a-dCTP by random priming (Feinberg and Vogelstein, 1983) and hybridized overnight at 688C in 5% SDS, 0.5 M sodium phosphate, pH 7.2 and 10 mg/ml denatured salmon sperm DNA. Blots were washed in 40 mM sodium phosphate, 0.5% SDS for 30 min at 688C (Church and Gilbert, 1984) .
For hybridization the following IMAGE cDNA clones were used: 182411 (EGR1), 150361 (IGF1R), 68599 (CSF1), 136821 (TGFb1), 157815 (RARa1), 248931 (BCL2), 153468 (C-MYC), 248613 (C-MYB), 77506 (Syndecan1), 53360 (novH), 667822 (non-muscle myosin heavy chain), 204679 (CAPL). All cDNA clones were obtained from the RZPD resource center, Berlin (Lennon et al., 1996) . PCR derived hybridization probes were synthesized using the Titan one tube RT ± PCR System (Boehringer) with the following primer pairs: B11-6 (caagtgtgtgagcacccaag, ggagtgggtcctatgcttgt) and D17-1 (tggtagggagaggactgtgc, ccatcctaggtgcctgtttg).
To validate the Northern blots a 28S oligonucleotide probe was hybridized on the ®lters as described by Barbu and Dautry (1989) and analysed with a Phosphorimager (Molecular Dynamics).
